{
    "title": "GSK shares fall as FTSE 100 pharma giant's blood cancer drug trial fails to meet its goal of outperforming existing market",
    "url": "https://www.dailymail.co.uk/money/markets/article-11398439/GSK-shares-fall-blood-cancer-drug-trial-fails-meet-goal.html",
    "date": "2022-11-07",
    "keywords": [
        "drug",
        "treatment",
        "blenrep",
        "cent",
        "demand",
        "glaxo",
        "share",
        "fund",
        "monday",
        "pharma",
        "trial",
        "cancer",
        "goal",
        "time",
        "market",
        "risk",
        "vaccine",
        "profit",
        "giant",
        "year",
        "investment",
        "account",
        "fee",
        "glaxosmithkline",
        "faller",
        "ftse",
        "company",
        "blood",
        "type",
        "myeloma",
        "marketthe",
        "group",
        "survival",
        "period",
        "person",
        "disease",
        "oncology",
        "area",
        "focus",
        "companythere",
        "light",
        "europe",
        "jp",
        "morgan",
        "data",
        "question",
        "approvability",
        "setting",
        "success",
        "price",
        "approval",
        "business",
        "dwf",
        "law",
        "firm",
        "paypoint",
        "margin",
        "forecast",
        "boost",
        "article",
        "health",
        "category",
        "setback",
        "week",
        "covid19the",
        "end",
        "capital",
        "isa",
        "trade",
        "month",
        "community",
        "model",
        "affiliate",
        "product",
        "money",
        "commission",
        "editorial",
        "independence",
        "investing",
        "platform"
    ],
    "category": [
        "money",
        "markets"
    ]
}